Public Health

Analysis of public health, social and public policy including impacts on  economics, open dialog, and social life. Articles on the topic of public health are translated into multiple languages.

Did the CDC Mislead Its Advisers on the RSV Antibody for Babies?

Did the CDC Mislead Its Advisers on the RSV Antibody for Babies?

SHARE | PRINT | EMAIL

The seizure risk could apply to all RSV monoclonal antibodies now approved, potentially affecting millions of newborns. If the CDC presents safety data in a way that downplays clear signals of harm, the promise of a “reformed” advisory process collapses before it begins.

Did the CDC Mislead Its Advisers on the RSV Antibody for Babies? Read Journal Article

Weaponized "Misinformation" to Bury Safety Concerns: The Case of RSV Monoclonal Antibodies

Weaponized “Misinformation” to Bury Safety Concerns: The Case of RSV Monoclonal Antibodies

SHARE | PRINT | EMAIL

A recent critique raises a number of claims regarding my article. This response addresses the substantive points directly, focusing solely on the evidence. When evaluating new interventions for healthy newborns, presenting the full safety record is not optional; it is a fundamental obligation.

Weaponized “Misinformation” to Bury Safety Concerns: The Case of RSV Monoclonal Antibodies Read Journal Article

Oxford Academic Says it’s Time to Start Paying People to Take Vaccines

Oxford Academic Says It’s Time to Start Paying People to Take Vaccines

SHARE | PRINT | EMAIL

It’s time to start paying people to take vaccines to boost take-up. That’s according to Dr. Raymond Duch, an Oxford academic writing in the Financial Times. This is the lesson he’s taken from the Covid pandemic, apparently.

Oxford Academic Says It’s Time to Start Paying People to Take Vaccines Read Journal Article

Join the Brownstone Community
Get our FREE Journal Newsletter